CrystalsFirst logo

CrystalsFirst

Turning Insights Into Medicines

VS
Standigm logo

Standigm

The workflow AI drug discovery company

Side-by-Side Comparison

Metric CrystalsFirst Standigm
Founded 2018 2015
Headquarters Hamburg, Germany Seoul, Korea South
Employees 18 25
Industry AI, Biotechnology, Health Care AI, Biotechnology, Health Care
Funding Stage Non Equity Assistance Series D
Total Funding $756.60K $371.24M
Funding Rounds 4 8
Business Model Not tracked yet B2B, SaaS, Platform
Revenue Model Not tracked yet Subscription, Licensing, Performance Based
Services Not tracked yet AI SaaS & API Solutions, Novel Target Identification, Hit & Lead Optimization, Pipeline Management, Data-Driven AI Platforms
Target Customers Not tracked yet Pharmaceutical Companies, Biotech Startups, Healthcare Research Institutes, Academic and Research Organizations
Taxonomy Drug Discovery, Structural Biology, Computational Modelling, Generative AI, Medicinal Chemistry, Crystal Structure, Target Interactions, Rational Design, Hit Expansion, Scaffold Hopping, Compound Generation, Therapeutic Compounds, Innovative Technology, Pharmaceutical Research AI Drug Discovery, Workflow AI, Target Identification, Lead Generation, Drug Repurposing, Molecular Design Workflow, DarkMolFactory, Standigm ASK, Standigm BEST, Standigm Insight, Deep Learning, Automation In Drug Discovery, Novel Target Identification, First-in-Class Lead Compounds
Website crystalsfirst.com standigm.com
CrystalsFirst logo

About CrystalsFirst

CrystalsFirst is a biotechnology startup with the slogan "Turning Insights Into Medicines." Founded in 2018 and headquartered in Germany, the company is focused on revolutionizing small molecule drug discovery through its proprietary MAGNET platform. This technology integrates structural biology, ge...

Standigm logo

About Standigm

Standigm, founded in 2015, is a pioneering workflow AI-driven drug discovery company headquartered in Korea South. The company specializes in utilizing artificial intelligence to streamline and expedite the drug discovery process, targeting industries such as AI, Biotechnology, Health Care, Pharmace...

Frequently Asked Questions

CrystalsFirst — Turning Insights Into Medicines. Standigm — The workflow AI drug discovery company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CrystalsFirst has raised $756.60K while Standigm has raised $371.24M.
CrystalsFirst and Standigm operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors CrystalsFirst, Standigm, and millions of companies for 40+ signal types.

One analytics cookie (Google Analytics). Cookie Policy